We-Linking

We-Linking operates in the neurotechnology and medical-device segment, with a focus on implantable brain-computer interfaces rather than general-purpose computing or consumer wearables. Its stated differentiation is the breadth of its in-house engineering, spanning flexible neural electrodes, neural acquisition and stimulation chips, implant packaging, and wireless power and data transfer. The company also describes a portable, high-channel-count research platform and capabilities for neural signal decoding and closed-loop neuromodulation, suggesting work across both research tooling and prospective clinical systems. Its engineering prototype combines multiple elements into a fully implantable system, an important distinction from companies focused only on software, external sensors, or a single device component. Funding stage and investor backing are also unknown. The most supportable characterization is a technically broad BCI developer serving medical and research applications, with differentiation centered on integrated hardware development rather than a demonstrated market lead.

We-Linking’s described trajectory is centered on progressing from core component development toward an integrated implantable BCI platform. The company was founded in 2019, and its profile identifies completion of an engineering prototype for a fully implantable system as a significant technical milestone. Its component work includes high-density flexible electrodes, a 128-channel low-power acquisition chip, a 32-channel integrated acquisition and stimulation chip, and wireless RF power and data transmission. Together, these capabilities indicate a development path from neural sensing and stimulation components to system-level integration. The company also describes a portable high-channel-count research platform and collaboration with hospitals and universities for clinical and research applications, which may support iterative testing and application development. Consequently, the evidence supports a technology-development narrative, but not a conclusion about revenue growth or commercialization speed.